← All companies
NEOGENOMICS INC
NEO - CIK 0001077183
Market cap$1.49 B
Rank#2325
SEC filings1,246
The table below shows NEOGENOMICS INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $159.62M | $367.01M | $342.49M | $263.18M | $316.83M | $228.71M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $159.24M | $150.54M | $131.23M | $119.71M | $112.13M | $106.84M |
| Inventory | $28.57M | $26.75M | $24.16M | $24.28M | $23.39M | $29.53M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.